Review

What Do Current Information and Evidence Suggest to Us for Oxytocin Use During Caesarean Section?

10.5152/TJAR.2014.76753

  • Berrin Günaydın
  • Ayça Taş Tuna

Received Date: 19.11.2014 Accepted Date: 03.12.2014 Turk J Anaesthesiol Reanim 2015;43(2):113-115

Oxytocin is the first-line agent in the prevention and treatment of uterine atony and maintenance of uterine tone. Since there are several different practices related to the use of oxytocin during caesarean sections, we would like to address the latest information and evidence for rational oxytocin use.

Keywords: Oxytocin, caesarean section, current information